Pricing Against Amazon
How a DPC's GLP-1 program wins on care, not price.
A positioning playbook for the modern DPC whose patients have started asking about Amazon's $149 GLP-1. Site language, Meet & Greet script, and FAQ ready to paste. Authored 2026-05-24.
About this playbook
On April 21, 2026, Amazon One Medical launched a nationwide cash-pay GLP-1 program at $149/month for the oral version, $299/month for the injectable, and $25/month for One Medical Insured members. The ads are running. The price is on the home page. Members on your panel have already seen it.
This playbook isn't an argument that you're cheaper. You're not. It's the language a modern DPC uses to explain, on the GLP-1 service page and in the Meet & Greet, why the program is built the way it is and what the members on it are paying for. Each section is an artifact you can paste into your site, hand to the front desk, or open the next Meet & Greet with. No theory. Nine moves, done.
Who this is for
Modern DPC owners running a GLP-1 program inside the membership. If your bundled price sits between $250 and $500 a month and your members have started forwarding Amazon's ad to your front desk, this playbook is for you. If you haven't launched a GLP-1 program yet, read it before you price one.
A note on the framing
This product doesn't tell you to drop your price. The price doesn't drop. The argument is supervision, dose adjustment, continuity. That's the position. Defensive copy that pretends Amazon isn't cheaper kills the trust on the rest of the page, so we don't do that either.
What Amazon launched and why it matters
The facts, plainly
On April 21, 2026, Amazon announced the Amazon One Medical GLP-1 Management Program. The program is nationwide. One Medical membership isn't required to schedule a visit. Most major insurance is accepted (copays apply). The cash-pay pricing is the headline 1.
- Oral GLP-1 (Wegovy pill / Foundayo), cash: from $149/month
- Injectable GLP-1, cash: from $299/month
- With One Medical-accepted insurance: as low as $25/month
- Cash-pay appointment fees: around $29 per visit, with 24/7 on-demand renewals for existing patients
- Same-day Amazon Pharmacy delivery in roughly 3,000 cities at launch, scaling toward 4,500 by year-end
Why this is different from previous GLP-1 telehealth
Hims, Ro, Mochi, and Henry have been selling compounded semaglutide and tirzepatide for two years. They live in healthcare-marketing channels. Amazon doesn't. Amazon's ad runs against everyone's Prime invoice and ships out of Amazon Pharmacy. It moves the conversation from "a telehealth brand I've heard of" to "the company that delivers everything." That's the shift. The price was always out there. The distribution wasn't.
What it means for your panel
Every member on a $250 to $500 bundled program now has a $149 anchor in their head. Some will ask. Some won't ask and will quietly switch. The job of the GLP-1 service page, and the job of the front desk on a Meet & Greet, is to give the member a clean reason why the program is built the way it is, before they have to ask twice.
The price comparison the member is doing
Say it plainly: Amazon is cheaper
The first move on the page is honesty. Amazon's $149 oral is less than your bundled program. Amazon's $299 injectable is less than most bundled injectable programs. If you try to argue around it, the member spots the dodge and stops reading.
A typical modern DPC GLP-1 program runs $250 to $500/month bundled. That's the public-pricing range in 2026 from our independent research and a scan of practice sites that publish cash prices. The bundle usually includes the medication, the labs, the visits, and the supervision. Amazon's $149 oral is the medication plus a brief telehealth visit. They're not the same product. They aren't priced like the same product. But on the surface, $149 is $149.
What the member sees side by side
A side-by-side from the member's chair looks like this:
| What the member compares | Amazon One Medical | A modern DPC bundled program |
|---|---|---|
| Headline cash price | $149/mo oral, $299/mo injectable | $250 to $500/mo bundled |
| Visit fee, cash | ~$29 per visit | Included in the bundle |
| Where the medication ships from | Amazon Pharmacy, same-day in major metros | Compounding pharmacy or your in-clinic dispensary |
| Who prescribes | A One Medical clinician they haven't met | Their doctor on the panel |
| Labs | Not included, billed separately | Usually included in the bundle |
| Follow-up cadence | On-demand, telehealth | Scheduled, with in-person check-ins |
The honest take: Amazon is the cheaper, faster transaction. Your program is a different thing.
Why the honesty matters
Members trust a doctor's site that doesn't try to win the argument on the wrong axis. If the page tries to convince them Amazon costs more once you "add it all up," they'll do the math themselves and catch the weasel. If the page says "Amazon is cheaper, here's what they don't do," they'll keep reading.
What Amazon's $149 doesn't include
This is the substance of the page. Each item is something Amazon's public program description either doesn't mention or explicitly substitutes with a leaner version 1.
No in-person initiation. Amazon's program is virtual. The first visit is a telehealth screen. A modern DPC initiates the GLP-1 program with a baseline labs panel, a body composition or BMI review, and a clinical conversation in the room. The in-person initiation is what catches the contraindications a brief virtual visit can miss, including thyroid history, pancreatitis history, gallbladder history, and current GI conditions.
Dose adjustment is limited. Amazon's protocol is algorithmic, and the on-demand renewal model is built for a stable maintenance dose. If the member is nauseated at 0.5 mg of semaglutide and needs to hold there for an extra month, or if they're not losing weight at 1.0 mg and need a different titration plan, that's a clinical conversation. A modern DPC has the relationship and the schedule to manage that. The algorithm doesn't.
No primary care relationship. Amazon's clinicians are good. They're also strangers. If the member develops a side effect that isn't GLP-1 (a new GI symptom that could be GLP-1 or could be something else), Amazon's path is to refer out. The DPC's path is to see the member tomorrow.
Labs aren't included. The Amazon program prices the medication and the visit. Labs are billed separately, on the member's insurance or out of pocket. A bundled DPC GLP-1 program usually includes the labs at 30, 60, and 90 days as part of the monthly fee.
No continuity if the member gets sick. A member on a GLP-1 who gets the flu, who's in the ER with dehydration, who's about to have a procedure that requires holding the medication, all of that is your call. Amazon doesn't make those calls. The pharmacy ships and the next renewal happens or it doesn't.
The cleanest framing: Amazon sells the medication. A modern DPC sells the relationship the medication runs inside.
The argument, three pillars
The three pillars are what the GLP-1 service page should be built on. Each pillar is concrete and ready to paste. No abstraction. No "personalized care."
Pillar 1. Supervision
The supervision pillar is the in-person initiation and the active management. It's specific, not aspirational.
- A baseline labs panel before the first dose: A1C, fasting glucose, lipid panel, thyroid (TSH and free T4), comprehensive metabolic panel, and liver enzymes
- A body composition or BMI measurement in the room
- A clinical conversation that covers thyroid history, pancreatitis history, gallbladder history, and current GI symptoms
- A documented contraindication review before the first prescription is written
This is what "supervised" means in practice. If your page uses the word "supervised" without naming the pieces, members read it as marketing. If the page lists the pieces, they read it as a doctor.
Pillar 2. Dose adjustment
Dose adjustment is the second pillar and it's the one Amazon's algorithmic model can't match. The protocol matters.
- A scheduled 30-day check-in, in person or via secure message, that reviews tolerability, weight trend, and any side effects
- A repeat labs draw at 90 days to monitor metabolic changes
- A documented plan for what happens if the member can't tolerate the standard titration (the hold pattern, the alternative formulations, the off-ramp)
- A direct line to the prescriber, not a portal queue
Pasted on the page, this reads as the doctor running the protocol.
A clean line to close the pillar
Dose adjustment based on tolerability and labs at your 30-day visit, with the doctor who initiated the program. Not an algorithm.
The argument, three pillars
Pillar 3. Continuity
Continuity is the pillar that lands the relationship piece. It's the one Amazon doesn't try to claim.
- A primary care relationship with the prescribing doctor for everything else: the flu, the new symptom, the medication interaction, the pre-op clearance
- A single chart that holds the GLP-1 program alongside everything else the member is being treated for
- A standing offer to see the member same-day or next-day when something comes up, not a 24/7 renewal queue
- The continuity to manage the off-ramp when the member hits their target weight and the maintenance question gets real
A modern DPC's argument isn't "we do GLP-1 better." It's "we do GLP-1 inside the relationship that handles everything else, so the program lives in your medical record and not in an account you'll close in a year."
Why the three pillars hold together
Members who try GLP-1 through a telehealth platform and stay on it for two years often end up looking for a doctor anyway, because the medication's clinical management gets complicated past the first 6 months. The three pillars are the answer to the question the member is going to ask in month 9 even if they aren't asking now. Your job is to put the answer on the page before the question lands.
The single sentence the three pillars roll up into
A GLP-1 program inside a primary care relationship, with the doctor who's seen your labs and knows your history. Initiation in the room, dose adjustment based on tolerability, continuity for everything else.
Service-page language, three lengths
Three versions of the GLP-1 service-page paragraph. Pick one and paste it. Each is visually distinct as a "copy this" block.
Short version (35 words)
Our GLP-1 program is supervised, in person, by the doctor on your panel. Initiation in the room. Dose adjustment based on tolerability and labs at your 30-day visit. Continuity for everything the medication runs alongside.
Medium version (95 words)
We run our GLP-1 program inside the membership relationship. The first visit is in the room, with a baseline labs panel and a contraindication review. The dose gets adjusted at your 30-day visit based on how you tolerated the starting dose and what the labs show. The doctor who started the program is the doctor you see for the flu, the new symptom, and the pre-op question. Amazon and the telehealth platforms can sell you the medication for less. They can't sell you the doctor who knows you. That's the trade.
Long version (185 words)
Our GLP-1 program is built on three things that don't fit in a $149 cash-pay transaction.
Supervision. The first visit is in person. We draw a baseline panel (A1C, fasting glucose, lipids, thyroid, CMP, liver enzymes), measure body composition, and review the contraindications that matter: thyroid history, pancreatitis history, gallbladder history, current GI symptoms. The prescription gets written after that conversation.
Dose adjustment. At day 30 we review tolerability and the weight trend. If you can't tolerate the standard titration, we hold or change the plan. Labs repeat at day 90. The doctor running the protocol is the doctor you message when something comes up at week 4 or week 11.
Continuity. The program lives in your medical record alongside everything else we manage for you. When you finish, the off-ramp gets managed in the relationship, not in an account you close.
Amazon's $149 oral and $299 injectable will be cheaper than our program. They will. They're a different product, and we're going to keep building ours the way we built it.
The Meet & Greet script
The Meet & Greet is where the prospective member asks the price question to the doctor's face. This is the answer. Two to three sentences. Owner language. Said the way a doctor talks, not a salesperson.
The script (say this)
"Amazon's program is real and it's cheaper. I'd be lying if I told you otherwise. What we're charging for is the in-person start, the dose adjustment with me, and the fact that when something else comes up you're calling the doctor who knows you, not a queue. If that's not worth the difference, Amazon's a fine choice and I'll tell you that straight."
The shorter version, for the doctor who likes it tighter
"Amazon is cheaper. They're selling the medication. We're selling the medication inside the relationship. If the relationship matters to you, this is the right place. If it doesn't, Amazon will do the job."
Why these work
The script names the gap before the member does. It refuses to oversell. It draws the line cleanly: medication versus relationship. A doctor who can say it without flinching ends the conversation with the member's trust intact, whether or not the member signs up that day. The members who say "I want the relationship" are the ones who stay on the panel. The members who say "I just want the prescription" are the ones who churn out in month 3 anyway. Better to lose them at the Meet & Greet than at month 3.
What not to say
Avoid: "But you get so much more value with us." Avoid: "Amazon doesn't really…" Avoid: "When you add it all up." Each of those is the dodge the member spots in real time. Honesty plus a clean pillar lands. Comparison spreadsheets lose.
The FAQ entry
Drop this single Q&A into the GLP-1 service page FAQ or the main practice FAQ. It's written for the member, not for another doctor.
The question
Q. Why does your GLP-1 program cost more than Amazon's?
The answer
Amazon's GLP-1 program is $149/month for the oral medication and $299/month for the injectable, paid cash. Ours is a bundled program that costs more than that. Here's what the difference is paying for.
The first visit is in person. Before we write the first prescription, we draw a labs panel (A1C, fasting glucose, lipids, thyroid, comprehensive metabolic panel, liver enzymes), look at body composition, and talk through the contraindications a video visit can miss. That conversation is included in the program.
The dose gets adjusted with the doctor who started it. At 30 days we check how you tolerated the starting dose, look at the weight trend, and either move up, hold, or change the plan. Labs repeat at 90 days. The doctor running the protocol is the same doctor you see for everything else.
The relationship covers everything around the medication. If you develop a side effect that might not be the GLP-1, if you need pre-op clearance, if you've got the flu and you're not sure whether to hold a dose, that's a call to us, not a queue. When you hit your weight goal and the maintenance question is on the table, we manage that here too.
The honest part. Amazon's medication is the same molecule. If the medication is all you want, Amazon will do the job and we'll tell you that. What costs more in our program is the relationship the medication runs inside. That's the choice.
When to refer out
The honesty section. The one that earns the rest of the playbook.
Not every patient is a fit for a modern DPC GLP-1 program. Some patients want the medication, on time, at the lowest cash price they can find, with no doctor visits and no labs they have to drive to. Amazon One Medical is built for that patient. So is Hims, Ro, Mochi, Henry, and a dozen others. They aren't bad medicine. They're a different model.
The patient who should choose Amazon, not you
- The patient who's been on a stable maintenance dose for over a year and wants on-demand refills
- The patient who can't afford the bundled cash price and would otherwise go without
- The patient who lives a hundred miles from your clinic and isn't going to make the in-person visits
- The patient who's clear they only want the medication and isn't interested in primary care
- The patient who already has a primary care doctor they like and just needs a GLP-1 prescriber
For those members, "we're a fit for you" isn't true. Saying it anyway burns the relationship the day they figure it out. Saying "Amazon's the right call for what you're describing" at the Meet & Greet keeps your name clean and the door open for the next referral they send you.
The job isn't to keep every patient
A DPC fills the panel with the members who want what the model is built for. The model is built for the member who wants the relationship. The panel works when those members stay. It doesn't work when you bend the program to fit the members who don't want it, because they leave anyway and the ones who wanted the relationship are watching.
The refer-out conversation is the practice's integrity move. It's also the move that turns a "no" into a referral six months later, when the same patient calls back because the on-demand model didn't catch the GI side effect at week 6.
About Massive Impact + book a call + sources
About Massive Impact
Massive Impact builds websites for modern DPC practices, the ones running GLP-1, hormone therapy, peptides, and longevity inside the membership relationship. The DPC Growth Site is the productized package. It ships with the GLP-1 service-page module already written in the positioning language in this playbook. One reference build is VitaLife Longevity Medicine, live at vitalifelongevitymed.com.
Book a call
The fastest move is a 20-minute call to walk through your current GLP-1 page and where the three pillars do or don't sit on it. If Amazon's launch has already shown up in your member conversations, the call's worth the 20 minutes.
Book it: [winmassiveimpact.com/dpc-zoom-call)
Direct email: [email protected]
Related reading
The full cash-pay service catalog (48 entries, all 10 categories, the GLP-1 entry expanded across the whole stack) is The DPC Practice Stack.
See it: [winmassiveimpact.com/dpc-zoom-call)
Sources
- Amazon, "Amazon One Medical launches nationwide GLP-1 management program," April 21, 2026. aboutamazon.com/news
- CNBC, "Amazon launches GLP-1 weight-loss program through One Medical," April 21, 2026. cnbc.com/2026
- Massive Impact's independent research of the US DPC market (n = 2,468 unique practices, 3,734 records, 108 fields, as of May 2026). DPC GLP-1 bundled-program pricing landscape drawn from practice sites that publish cash pricing.
- Healthcare Dive, "Amazon One Medical adds GLP-1 management program," April 21, 2026. healthcaredive.com/news
License the research
The underlying research is available as a licensed dataset on request. Request details: [winmassiveimpact.com/request-research) or [email protected].
The rest of the report is yours, free.
Enter your email to keep reading and get the PDF to keep.
No spam. One email unlocks every Massive Impact report.
